Excited to share that our CEO, Mr. Clement Tam, represented ZERO Biotech at the “Mix & Mingle: The Cancer MedTech Translational Hub” event on 5th June 2026 at the Hong Kong Science Park.
Clement delivered a compelling presentation on “Radiopharmaceuticals for Future Cancer Care”, sharing insights into our work advancing targeted radionuclear cancer diagnostics and therapies. It was a fantastic platform to connect with fellow innovators, clinicians, investors, and industry leaders driving breakthroughs in oncology.
A big thank you to the HKSTP organizers for curating such a vibrant evening of knowledge exchange and partnership-building. Events like these truly accelerate the translation of MedTech innovations from bench to bedside.
Proud to be part of this growing Cancer MedTech community in Hong Kong!
Looking forward to future collaborations that will shape the next wave of cancer care.